Private Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.3M Sell
4,675
-724
-13% -$734K 0.33% 45
2025
Q4
$5.8M Buy
5,399
+612
+13% +$585K 0.41% 40
2025
Q3
$3.65M Sell
4,787
-850
-15% -$633K 0.26% 55
2025
Q2
$4.39M Buy
5,637
+250
+5% +$194K 0.34% 46
2025
Q1
$4.45M Buy
5,387
+358
+7% +$298K 0.37% 48
2024
Q4
$3.88M Sell
5,029
-386
-7% -$320K 0.3% 52
2024
Q3
$4.8M Buy
5,415
+955
+21% +$859K 0.38% 44
2024
Q2
$4.04M Buy
4,460
+580
+15% +$464K 0.3% 45
2024
Q1
$3.02M Sell
3,880
-850
-18% -$605K 0.24% 50
2023
Q4
$2.76M Buy
4,730
+1,145
+32% +$668K 0.23% 48
2023
Q3
$1.93M Buy
3,585
+1,140
+47% +$587K 0.18% 53
2023
Q2
$1.15M Sell
2,445
-12
-0.5% -$5.03K 0.11% 70
2023
Q1
$844K Buy
+2,457
New +$829K 0.08% 90
2021
Q1
Sell
-1,569
Closed -$265K 96
2020
Q4
$265K Sell
1,569
-500
-24% -$74.7K 0.03% 103
2020
Q3
$306K Hold
2,069
0.04% 92
2020
Q2
$340K Hold
2,069
0.05% 88
2020
Q1
$287K Hold
2,069
0.05% 99
2019
Q4
$272K Hold
2,069
0.04% 108
2019
Q3
$231K Buy
+2,069
New +$230K 0.04% 112
2019
Q2
Sell
-1,750
Closed -$227K 137
2019
Q1
$227K Sell
1,750
-900
-34% -$109K 0.04% 112
2018
Q4
$307K Sell
2,650
-93
-3% -$10.4K 0.06% 81
2018
Q3
$294K Buy
2,743
+93
+4% +$9.3K 0.04% 103
2018
Q2
$226K Hold
2,650
0.04% 110
2018
Q1
$205K Sell
2,650
-2,800
-51% -$225K 0.04% 121
2017
Q4
$460K Hold
5,450
0.09% 94
2017
Q3
$466K Sell
5,450
-300
-5% -$24.6K 0.09% 93
2017
Q2
$473K Hold
5,750
0.1% 84
2017
Q1
$484K Sell
5,750
-2,325
-29% -$186K 0.11% 81
2016
Q4
$594K Sell
8,075
-100
-1% -$7.45K 0.14% 75
2016
Q3
$656K Sell
8,175
-1,000
-11% -$80K 0.16% 76
2016
Q2
$723K Hold
9,175
0.17% 77
2016
Q1
$661K Sell
9,175
-3,825
-29% -$289K 0.16% 81
2015
Q4
$1.09M Buy
13,000
+7,000
+117% +$581K 0.26% 73
2015
Q3
$502K Buy
6,000
+600
+11% +$50.7K 0.13% 100
2015
Q2
$451K Hold
5,400
0.1% 104
2015
Q1
$392K Sell
5,400
-250
-4% -$17.8K 0.09% 115
2014
Q4
$390K Hold
5,650
0.09% 117
2014
Q3
$366K Buy
5,650
+1,000
+22% +$63.3K 0.08% 135
2014
Q2
$289K Sell
4,650
-800
-15% -$47.7K 0.06% 135
2014
Q1
$321K Hold
5,450
0.08% 129
2013
Q4
$278K Hold
5,450
0.06% 151
2013
Q3
$274K Hold
5,450
0.06% 150
2013
Q2
$268K Buy
+5,450
New +$297K 0.07% 150

Other funds holding LLY

Private Wealth Partners's LLY Position: Q1 2026 in Review

Private Wealth Partners reduced its Eli Lilly (LLY) stake by 13% in Q1 2026, selling an estimated $734K and leaving 4,675 shares worth $4.3M. The position accounts for 0.33% of the portfolio, ranked #45.

Private Wealth Partners first reported a position in LLY in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.8M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Private Wealth Partners held 4,675 shares of Eli Lilly worth $4.3M as of Q1 2026.
  • Private Wealth Partners sold 724 Eli Lilly shares in Q1 2026, an estimated $734K.
  • Eli Lilly made up 0.33% of Private Wealth Partners's portfolio in Q1 2026, its #45 holding.
  • Private Wealth Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 43 quarters since.
  • Private Wealth Partners's Eli Lilly position peaked at $5.8M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.